Larson, S. M., Osborne, J. R., Grewal, R. K., & Tuttle, R. M. (2017). Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer. Mol Imaging Radionucl Ther.
Chicago Stili AlıntıLarson, Steven M., Joseph R. Osborne, Ravinder K. Grewal, ve R. Michael Tuttle. "Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer." Mol Imaging Radionucl Ther 2017.
MLA AlıntıLarson, Steven M., Joseph R. Osborne, Ravinder K. Grewal, ve R. Michael Tuttle. "Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer." Mol Imaging Radionucl Ther 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..